Compliance


7 Things to Consider in Medicinal Cannabis Development
7 Things to Consider in Medicinal Cannabis Development
February 21, 2019

Mention the word cannabis and the confusion starts; legal or illegal, nutraceutical…

Read More
Industry Poll: How Can Your GMP Auditing Program Be Most Improved
Industry Poll: How Can Your GMP Auditing Program Be Most...
November 29, 2018

Recently, ProPharma Group conducted a poll to quality professionals across the country…

Read More
Implementing a Risk-Based Supplier Management Program
Implementing a Risk-Based Supplier Management Program
July 10, 2018

According to recent FDA updates on the implementation of the Safety and…

Read More
What to Expect From a FDA Inspection, Part 2
What to Expect From a FDA Inspection, Part 2
March 28, 2018

In this continuation from “Preparing for an FDA Inspection” I will discuss…

Read More
Preparing for a FDA Inspection, Part 1
Preparing for a FDA Inspection, Part 1
March 8, 2018

  The ultimate goal of the U.S. Food and Drug Administration is…

Read More
FDA’s Top 483 Observations for 2017: A Reflection of Industry’s Compliance
FDA’s Top 483 Observations for 2017: A Reflection of Industry’s...
January 10, 2018

At the beginning of each federal fiscal year, the US FDA posts…

Read More
Contact Us